首页> 美国卫生研究院文献>Oncotarget >Novel histopathologic feature identified through image analysis augments stage II colorectal cancer clinical reporting
【2h】

Novel histopathologic feature identified through image analysis augments stage II colorectal cancer clinical reporting

机译:通过图像分析确定的新型组织病理学特征增强了II期结直肠癌的临床报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A number of candidate histopathologic factors show promise in identifying stage II colorectal cancer (CRC) patients at a high risk of disease-specific death, however they can suffer from low reproducibility and none have replaced classical pathologic staging. We developed an image analysis algorithm which standardized the quantification of specific histopathologic features and exported a multi-parametric feature-set captured without bias. The image analysis algorithm was executed across a training set (n = 50) and the resultant big data was distilled through decision tree modelling to identify the most informative parameters to sub-categorize stage II CRC patients. The most significant, and novel, parameter identified was the ‘sum area of poorly differentiated clusters’ (AreaPDC). This feature was validated across a second cohort of stage II CRC patients (n = 134) (HR = 4; 95% CI, 1.5– 11). Finally, the AreaPDC was integrated with the significant features within the clinical pathology report, pT stage and differentiation, into a novel prognostic index (HR = 7.5; 95% CI, 3–18.5) which improved upon current clinical staging (HR = 4.26; 95% CI, 1.7– 10.3). The identification of poorly differentiated clusters as being highly significant in disease progression presents evidence to suggest that these features could be the source of novel targets to decrease the risk of disease specific death.
机译:许多候选的组织病理学因素显示出在确定罹患特定疾病死亡风险高的II期结直肠癌(CRC)患者中的希望,但是它们的重现性很低,没有一个能够替代经典的病理分期。我们开发了一种图像分析算法,该算法标准化了特定组织病理学特征的量化,并导出了无偏差捕获的多参数特征集。在训练集(n = 50)上执行图像分析算法,并通过决策树模型提取所得的大数据,以识别最有用的参数,以对II期CRC患者进行亚分类。确定的最重要,最新颖的参数是“低分化集群的总面积”(AreaPDC)。在第二期CRC患者中(n = 134)(HR = 4; 95%CI,1.5-11),这一特征得到了验证。最后,将AreaPDC与临床病理报告,pT分期和分化中的重要特征整合为一个新的预后指标(HR = 7.5; 95%CI,3-18.5),该分期在当前临床分期中有所改善(HR = 4.26; 95%CI,1.7–10.3)。将低分化簇鉴定为在疾病进展中高度重要的证据表明,这些特征可能是降低疾病特异性死亡风险的新靶标的来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号